Corporate Profile

Eargo is a medical device company on a mission to improve hearing health. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated, exempt Class I or Class II devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. The Eargo device is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

17 Aug '22
Company Applauds FDA for Increased Access, Innovation SAN JOSE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc.  (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, announced its support of the new regulatory category of over-the-counter
08 Aug '22
Financing Update: Strengthened financial position with up to $125 million strategic investment from Patient Square Capital (the “Note Transaction”); closed first tranche investment of $100 million senior secured convertible notes on June 28, 2022 Company intends to seek stockholder approval to